title: Laparoscopic fundoplication with or without pyloroplasty in patients with gastroesophageal reflux disease after lung transplantation: how I do it.
abstract: BACKGROUND
  Several studies have confirmed that gastroesophageal reflux disease (GERD) in lung transplant patients is a risk factor for the development and progression of bronchiolitis obliterans syndrome (BOS), a form of rejection after lung transplantation. Moreover, numerous reports indicate that surgical correction of GERD may control the decline in lung function characteristic of BOS. Although laparoscopic fundoplication is an accepted treatment option for these patients with GERD, the surgical technique, which often includes a laparoscopic pyloroplasty, has not been standardized.
  
  
  METHODS
  The purpose of this article is to describe a step-by-step approach to the laparoscopic treatment of GERD in lung transplant patients. We also address specific technical concerns encountered in the surgical management of this high-risk patient population; we provide data on the safety of this operation; and we illustrate the evidence-based rationale for each technical step of the procedure.
authors.affiliation: Department of Surgery, Loyola University Medical Center, Maywood, IL 60153, USA.
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Davis
authors.forename: W Scott
authors.initials: WS
authors.lastname: Jellish
authors.forename: P Marco
authors.initials: PM
authors.lastname: Fisichella
mesh_terms: D001989:Bronchiolitis Obliterans / Q000517:prevention & control; D018662:Fundoplication / Q000379:methods*; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000601:surgery*; D015391:Gastroplasty / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D016031:Liver Transplantation / Q000009:adverse effects*; D011708:Pylorus / Q000601:surgery*; D012307:Risk Factors; D016896:Treatment Outcome